ArticleDiabetes, obesity & metabolism2025
Socio-demographic and clinical factors associated with the receipt of anti-obesity medication prescriptions and metabolic and bariatric surgery among eligible all of Us participants.
Article in Diabetes, obesity & metabolism, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
6 citing papers in PubMed.
- Development, structure, and implementation of cardiometabolic clinics in the United States, with a focus on comprehensive patient care.American journal of preventive cardiology · 2026Review
- Obesity Treatments and Weight Changes in Clinical Practice After Discontinuation of Semaglutide or Tirzepatide.Diabetes, obesity & metabolism · 2026Article
- Trends in Use of Obesity Medications and Metabolic and Bariatric Surgery Among All of Us Participants From 2003 to 2023.Obesity (Silver Spring, Md.) · 2026Article
- Understanding obesity treatment choices: a mixed-methods study of patient preferences and shared decision-making.Translational behavioral medicine · 2026Article
- 12-Month Weight Loss and Adherence Predictors in a Real-World UK Tirzepatide-Supported Digital Obesity Service: A Retrospective Cohort Analysis.Healthcare (Basel, Switzerland) · 2025Article
- Socio-demographic and clinical factors associated with the receipt of anti-obesity medication prescriptions and metabolic and bariatric surgery among eligible all of Us participants.Diabetes, obesity & metabolism · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
aimsThere is a paucity of data on socio-economic characteristics associated with the use of anti-obesity medications (AOM) and metabolic and bariatric surgery (MBS) when accounting for clinical factors. This study characterized factors associated with the receipt of AOM prescriptions and MBS. MATERIALS AND
methodsA cross-sectional study was conducted using the All of Us (AoU) Research (v.8) data. Patients with obesity who received AOM or MBS between 2017 and 2023 were included. Descriptive statistics were used to summarize patient characteristics, while multivariable regression examined factors associated with the receipt of the treatments.
resultsOnly 6.6% of 183 424 patients for AOM analysis, received an AOM prescription, while 1.8% underwent MBS among 93 146 patients. Being a man (vs. woman, adjusted odds ratio [aOR] = 0.62, 95% confidence interval [CI], 0.59-0.65), Medicare insurance holder (vs. private, aOR = 0.78, 95% CI, 0.72-0.84), retiree (vs. employed, aOR = 0.70, 95% CI, 0.66-0.75) and high school degree holders (vs. college, aOR = 0.85, 95% CI, 0.80-0.90) were associated with lower odds of receiving AOM. Being single (vs. married, aOR = 0.84, 95% CI, 0.74-0.96), retired (vs. employed, aOR = 0.63, 95% CI, 0.49-0.80), with body mass index (BMI) 35- < 40 (vs. ≥45, aOR = 0.13, 95% CI, 0.11-0.15) were associated with lower odds of MBS. Patients with dyslipidaemia and obstructive sleep apnoea had higher odds of receiving both treatments.
conclusionsDisparities in obesity treatment exist. Male sex, older age, lower income and lower BMI were associated with lower odds of treatment, while dyslipidaemia and obstructive sleep apnoea were associated with higher odds.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.